Liraglutide 3 mg on weight, body composition, and hormonal and metabolic parameters in women with obesity and polycystic ovary syndrome: a randomized placebo-controlled-phase 3 study-Reference-Cited by-同舟云学术

Liraglutide 3 mg on weight, body composition, and hormonal and metabolic parameters in women with obesity and polycystic ovary syndrome: a randomized placebo-controlled-phase 3 study

Published:2022-08 Issue:2 Volume:118 Page:371-381
ISSN:0015-0282
Container-title:Fertility and Sterility
language:en
Short-container-title:Fertility and Sterility

Author:

Elkind-Hirsch Karen E.,Chappell Neil,Shaler Donna,Storment John,Bellanger Drake

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Reproductive Medicine

Reference49 articles.

1. The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria;March;Hum Reprod,2010

2. Impact of obesity on the risk for polycystic ovary syndrome;Yildiz;J Clin Endocrinol Metab,2008

3. Overweight, obesity and central obesity in women with polycystic ovary syndrome: a systematic review and meta-analysis;Lim;Hum Reprod Update,2012

4. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis;Dunaif;Endocr Rev,1997

5. Lifestyle changes in women with polycystic ovary syndrome;Moran;Cochrane Database Syst Rev,2011

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The efficacy and safety of GLP-1 agonists in PCOS women living with obesity in promoting weight loss and hormonal regulation: A meta-analysis of randomized controlled trials;Journal of Diabetes and its Complications;2024-10

2. Semaglutide Alleviates Ovary Inflammation via the AMPK/SIRT1/NF‑κB Signaling Pathway in Polycystic Ovary Syndrome Mice;Drug Design, Development and Therapy;2024-09

3. Optimizing obesity management for women in an Indian obstetrics and gynecology setting: A consensus approach by the Indian Society of Assisted Reproduction (ISAR);Indian Journal of Obstetrics and Gynecology Research;2024-08-15

4. Clinical Effects of Glucagon-Like Peptide-1 Agonist Use for Weight Loss in Women With Polycystic Ovary Syndrome: A Scoping Review;Cureus;2024-08-12

5. Liraglutide improves follicle development in polycystic ovary syndrome by inhibiting CXCL10 secretion;Reproductive Biology and Endocrinology;2024-08-06